Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

<p>Phosphoproteins</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Xiaoqing Cheng (16918496) (author)
Altres autors:	Yirui Sun (16918499) (author), Maureen Highkin (16918502) (author), Nagalaxmi Vemalapally (16918505) (author), Xiaohua Jin (16918508) (author), Brandon Zhou (16918511) (author), Julie L. Prior (16918514) (author), Ashley R. Tipton (16918517) (author), Shunqiang Li (15123195) (author), Anton Iliuk (16918520) (author), Samuel Achilefu (11605234) (author), Ian S. Hagemann (15026769) (author), John R. Edwards (16918523) (author), Ron Bose (15045749) (author)
Publicat:	2025
Matèries:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Biological Agents & Therapies Antibody-drug conjugates Antireceptors Breast Cancer Cell Cycle CDKs and CDK inhibitors Preclinical Models Organoids
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Table S2 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
per: Xiaoqing Cheng (16918496)
Publicat: (2025)

Table S3 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
per: Xiaoqing Cheng (16918496)
Publicat: (2025)

Table S4 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
per: Xiaoqing Cheng (16918496)
Publicat: (2025)

Table S5 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
per: Xiaoqing Cheng (16918496)
Publicat: (2025)

Table S6 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
per: Xiaoqing Cheng (16918496)
Publicat: (2025)

<i>N. brasiliensis</i> infection is comparable between iLck<sup>cre</sup>IL-4Rα<sup>−/lox</sup> and Lck<sup>cre</sup>IL-4Rα<sup>−/lox</sup> mice.
per: Saskia Schmidt (109610)
Publicat: (2025)

Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
per: Takeru Oka (15386810)
Publicat: (2025)

Supplementary Table S1 from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
per: Takeru Oka (15386810)
Publicat: (2025)

<i>N. brasiliensis</i> infection is comparable between BALB/c and IL-4Rα<sup>−/lox</sup> mice.
per: Saskia Schmidt (109610)
Publicat: (2025)

Graphical representation of the main components of the network of interactions in a single FIR for June 28<sup><i>th</i></sup>, 2019.
per: Raúl López-Martín (21386066)
Publicat: (2025)

Supplementary Table 1 from <i>N<sup>6</sup></i>-Methyladenosine Promotes Translation of VEGFA to Accelerate Angiogenesis in Lung Cancer
per: Haisheng Zhang (16436982)
Publicat: (2025)

Information about number of flights deleted during the pre-processing of the trajectory data, for June 28<sup><i>th</i></sup>, 2019.
per: Raúl López-Martín (21386066)
Publicat: (2025)

The 60 leading crops cultivated in Brazil, the economic value of pollination (EVP) of the harvest in 2019 and the degree of pollination dependence. Information on the degree of cropland dependence on pollinators are sourced from Klein et al. (2007), much of which are reiterated in Roubik (2018)<sup>1</sup>; Giannini et al. (2015)<sup>2</sup>; Campbell et al. (2018)<sup>3</sup> and Dorneles <i>et al</i>. (2013)<sup>4.</sup>
per: Willams Oliveira (21442562)
Publicat: (2025)

Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
per: Jiachun Su (16990970)
Publicat: (2025)

Figure S1 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
per: Dahihm Kim (16546203)
Publicat: (2025)

Figure S2 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
per: Dahihm Kim (16546203)
Publicat: (2025)

Figure S3 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
per: Dahihm Kim (16546203)
Publicat: (2025)

Figure S4 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
per: Dahihm Kim (16546203)
Publicat: (2025)

Figure S5 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
per: Dahihm Kim (16546203)
Publicat: (2025)

Table S1 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
per: Dahihm Kim (16546203)
Publicat: (2025)

Table S3 from Ccr2<sup>+</sup> Monocyte-Derived Macrophages Influence Trajectories of Acquired Therapy Resistance in <i>Braf</i>-Mutant Melanoma
per: Dahihm Kim (16546203)
Publicat: (2025)

3D live confocal image of live tissue previously passed through a sieve, from Myosin 1e <sup>+/</sup><sup>Flox</sup> ROSA <sup>+/</sup><sup>mTmG </sup>Podocin-Cre <sup>+/</sup><sup>Tg</sup> transgenic mouse
per: Yoseph Loyd (22623104)
Publicat: (2025)

3D confocal imaging data of podocyte membranes from manually sectioned renal tissue from a Myosin 1e <sup>+/</sup><sup>Flox</sup> ROSA <sup>+/</sup><sup>mTmG</sup> Podocin-Cre <sup>+/</sup><sup>Tg</sup> transgenic mouse.
per: Yoseph Loyd (22623104)
Publicat: (2025)

Supplemental Tables 1-8 from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated <i>SPP1</i><sup>+</sup> Macrophages and Fibroblasts
per: Anuja Sathe (15028097)
Publicat: (2025)

Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m<sup>6</sup>A Modification
per: Shuwei Li (16437116)
Publicat: (2025)

Cross sections for dissociative recombination of ArH<sup>+</sup> and NeH<sup>+</sup> calculated using MQDT
per: Åsa Larson (22660418)
Publicat: (2025)

Predicted values of C-reactive protein in patients with low BMI and high BMI, according to the relative abundance of <i>Alistipes shahii</i> patients with SLE (R<sup>2</sup> = 0.23; <i>P</i> value of the interaction = 0.03).
per: Lourdes Chero-Sandoval (22683418)
Publicat: (2025)

Confocal section of a paraformaldehyde-fixed cryosection of kidney cortex from Myo1e <sup>+/Flox</sup><sup> </sup>ROSA <sup>+/mTmG</sup>Podocin-Cre <sup>+/Tg</sup> transgenic mouse stained with antibodies against ZO-1 and DAPI
per: Mira Krendel (10712091)
Publicat: (2025)

CBQoL survey results<sup>‡.</sup>
per: Richard C. Trevino (22676460)
Publicat: (2025)

Supplementary Data from The m<sup>6</sup>A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I–Mediated Immune Response
per: Lei Zhang (15617910)
Publicat: (2025)

Supplementary Tables S1-14 from Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple <i>PIK3CA</i> Mutations
per: Smruthy Sivakumar (15053536)
Publicat: (2025)

SIBER density plots computed via Bayesian analysis using corrected δ<sup>15</sup>N and δ<sup>13</sup>C values.
per: Fee Nanett Trau (16734722)
Publicat: (2025)

ColorDx performance by EnChroma use<sup>‡.</sup>
per: Richard C. Trevino (22676460)
Publicat: (2025)

UMAP visualizations of extracted CD8<sup> + </sup> T and CD4<sup> + </sup> T cell barcodes, employed for downstream subsequent single-cell trajectory and classification analyses.
per: Fatemeh Keikha (20917848)
Publicat: (2025)

Table S1 from Dysregulation of Mitochondrial Translation Caused by <i>CBFB</i> Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer
per: Navdeep Malik (15293148)
Publicat: (2025)

Table S2 from Dysregulation of Mitochondrial Translation Caused by <i>CBFB</i> Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer
per: Navdeep Malik (15293148)
Publicat: (2025)

Table S3 from Dysregulation of Mitochondrial Translation Caused by <i>CBFB</i> Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer
per: Navdeep Malik (15293148)
Publicat: (2025)

Table S4. from Dysregulation of Mitochondrial Translation Caused by <i>CBFB</i> Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer
per: Navdeep Malik (15293148)
Publicat: (2025)

The dataset of Co<sup>2</sup>FuLL, paper accepted by ASE'25
per: Chaopeng Dong (15421424)
Publicat: (2025)

Supplementary Tables from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
per: Craig M. Goodwin (14955973)
Publicat: (2025)

Cannot write session to /tmp/vufind_sessions/sess_ikvc1c20j1ef8dckqibj59q216